Chapitre 3 : Prise en charge médicale de la douleur associée à l'endométriose
article
OA: bronze
CC0
AI-generated summary
This chapter reviews the medical management of pain associated with endometriosis, discussing various pharmacological and non-pharmacological treatment options.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (42)
- Action of danazol on plasma lipids and lipoprotein metabolism. via openalex
- Add-back therapy in the treatment of endometriosis-associated pain via openalex
- A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Chocolate cysts from ovarian follicles via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties via openalex
- Danazol for pelvic pain associated with endometriosis via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Does Response to Hormonal Therapy Predict Presence or Absence of Endometriosis? via openalex
- Effect of norethindrone acetate in the treatment of symptomatic endometriosis. via openalex
- Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. via openalex
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
- Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain. via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis via openalex
- Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex
- Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2159803441 via openalex
- W2074845402 via openalex
- W2019272525 via openalex
- W2010311608 via openalex
- W1990697327 via openalex
- W1969539871 via openalex
- W6672127118 via openalex
- W6683952698 via openalex
- W6715458637 via openalex
- W6716955854 via openalex
- W6824378097 via openalex
- W2123134517 via openalex
- W2101417341 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK